Analysis | Metabolite Name | Measured Value | Units | Gender | Glycemic status | Neuropathy |
---|---|---|---|---|---|---|
Reversed phase NEGATIVE ION MODE | GLUCOSE (M+CL)- | 232309 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCOSE (M+CL)- | 370314 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCOSE (M+CL)- | 591315 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCOSE (M+CL)- | 666707 | Peak area normalized | male | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCOSE (M+CL)- | 669312 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCOSE (M+CL)- | 676231 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCOSE (M+CL)- | 685356 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCOSE (M+CL)- | 701284 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCOSE (M+CL)- | 708559 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCOSE (M+CL)- | 722689 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCOSE (M+CL)- | 746681 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCOSE (M+CL)- | 767110 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCOSE (M+CL)- | 831843 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase NEGATIVE ION MODE | GLUCOSE (M+CL)- | 1231678 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | GLUCOSE (2M+NA)+ | 2694 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | GLUCOSE (2M+NA)+ | 4327 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | GLUCOSE (2M+NA)+ | 6935 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | GLUCOSE (2M+NA)+ | 7486 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | GLUCOSE (2M+NA)+ | 40770 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | GLUCOSE (2M+NA)+ | Peak area normalized | female | diabetic | Neuropathy | |
Reversed phase POSITIVE ION MODE | GLUCOSE (2M+NA)+ | Peak area normalized | female | diabetic | no neuropathy | |
Reversed phase POSITIVE ION MODE | GLUCOSE (2M+NA)+ | Peak area normalized | female | normoglycemic | no neuropathy | |
Reversed phase POSITIVE ION MODE | GLUCOSE (2M+NA)+ | Peak area normalized | male | diabetic | Neuropathy | |
Reversed phase POSITIVE ION MODE | GLUCOSE (2M+NA)+ | Peak area normalized | male | diabetic | no neuropathy | |
Reversed phase POSITIVE ION MODE | GLUCOSE (2M+NA)+ | Peak area normalized | male | pre-diabetic | Neuropathy | |
Reversed phase POSITIVE ION MODE | GLUCOSE (2M+NA)+ | Peak area normalized | male | pre-diabetic | no neuropathy | |
Reversed phase POSITIVE ION MODE | GLUCOSE (M+NA)+ | 8875 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | GLUCOSE (M+NA)+ | 9893 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | GLUCOSE (M+NA)+ | 45729 | Peak area normalized | male | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | GLUCOSE (M+NA)+ | 48138 | Peak area normalized | male | pre-diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | GLUCOSE (M+NA)+ | 54510 | Peak area normalized | female | normoglycemic | Neuropathy |
Reversed phase POSITIVE ION MODE | GLUCOSE (M+NA)+ | 72090 | Peak area normalized | male | pre-diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | GLUCOSE (M+NA)+ | 78262 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | GLUCOSE (M+NA)+ | 86457 | Peak area normalized | female | normoglycemic | no neuropathy |
Reversed phase POSITIVE ION MODE | GLUCOSE (M+NA)+ | 160377 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | GLUCOSE (M+NA)+ | 186509 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | GLUCOSE (M+NA)+ | 199533 | Peak area normalized | female | diabetic | Neuropathy |
Reversed phase POSITIVE ION MODE | GLUCOSE (M+NA)+ | 380529 | Peak area normalized | female | diabetic | no neuropathy |
Reversed phase POSITIVE ION MODE | GLUCOSE (M+NA)+ | Peak area normalized | female | diabetic | no neuropathy | |
Reversed phase POSITIVE ION MODE | GLUCOSE (M+NA)+ | Peak area normalized | male | diabetic | Neuropathy |